GlassScriptPhysician profile
Keith Richard Conti
NPI 1194395350
$2,758.19
in general payments reported to CMS, 2019-2025
22 companies · $1,222 in 2025
The $1,222 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $562 · 2023: $407 · 2024: $437 · 2025: $1,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,066.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $590.05 | 2023-2025 | |
| Glaxosmithkline, LLC. | $422.40 | 2022-2025 | Nucala |
| Optinose US, INC. | $383.50 | 2022-2025 | |
| Medtronic, INC. | $205.21 | 2024-2025 | Nim Vital, Pteye Parathyroid Detection System, Ligasure |
| Regeneron Healthcare Solutions, INC. | $171.74 | 2022-2025 | Dupixent |
| Stryker Corporation | $130.28 | 2021 | |
| Neurent Medical Limited | $129.55 | 2022 | |
| Csl Behring | $125.00 | 2024 | Hizentra |
| Phathom Pharmaceuticals, INC. | $124.74 | 2025 | Voquezna |
| Harmony Biosciences LLC | $101.33 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.51 | 2024-2025 | Cuvitru |
| Astrazeneca Pharmaceuticals LP | $57.17 | 2025 | Tezspire, Airsupra |
| Rayner Intraocular Lenses Limited | $50.97 | 2023-2024 | Omidria, Rayone Aspheric, Rayone Emv |
| Ani Pharmaceuticals, INC. | $31.28 | 2025 | Purified Cortrophin Gel |
| Biocryst US Sales Co., LLC | $30.54 | 2025 | Orladeyo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $22.83 | 2025 | Vest Therapy Und |
| Olympus Corporation of The Americas | $20.25 | 2023 | Olympus |
| Lilly USA, LLC | $18.79 | 2025 | Zepbound |
| Avadel Cns Pharmaceuticals, LLC | $17.10 | 2025 | Lumryz |
| Axsome Therapeutics, INC. | $16.73 | 2023 | Sunosi |
| Hologic Sales and Service, LLC | $16.64 | 2024 | Coolseal Generator |
| Inspire Medical Systems, INC. | $15.58 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Conti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.